Panlong Pharmaceutical: First Repurchase of 116,200 Company Shares

Panlong Pharmaceutical announced that the company previously deliberated and approved a share repurchase plan, intending to use RMB 10 million to RMB 20 million of its own funds to repurchase shares through centralized bidding, for use in an employee stock ownership plan or equity incentive, with the repurchase period being within 12 months from the date of approval by the board of directors; later, due to the semi-annual equity distribution, the upper limit of the repurchase price was adjusted from RMB 35.92 per share to RMB 35.82 per share. On October 21, 2026, the company repurchased shares for the first time, totaling 116,175 shares, accounting for 0.085% of the total share capital, with the highest transaction price at RMB 20.29 per share and the lowest transaction price at RMB 20.25 per share, and the total transaction amount was RMB 2.3550 million. The company will continue to advance the repurchase matter subsequently.